BP819
Cefazolin sodium
British Pharmacopoeia (BP) Reference Standard
Manufacturer: Sigma Aldrich
CAS Number: 27164-46-1
Synonym(S): Cefazolin sodium salt
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| 150 MG | BP819-150-MG | In Stock | ₹ 25,200.60 |
BP819 - 150 MG
In Stock
Quantity
1
Base Price: ₹ 25,200.60
GST (18%): ₹ 4,536.108
Total Price: ₹ 29,736.708
grade
pharmaceutical primary standard
API family
cefazolin
form
powder
shelf life
limited shelf life, expiry date on the label
manufacturer/tradename
BP
application(s)
pharmaceuticalpharmaceutical small molecule
format
neat
storage temp.
2-8°C
SMILES string
[Na+].Cc1nnc(SCC2=C(N3[C@H](SC2)[C@H](NC(=O)Cn4cnnn4)C3=O)C([O-])=O)s1
InChI
1S/C14H14N8O4S3.Na/c1-6-17-18-14(29-6)28-4-7-3-27-12-9(11(24)22(12)10(7)13(25)26)16-8(23)2-21-5-15-19-20-21;/h5,9,12H,2-4H2,1H3,(H,16,23)(H,25,26);/q;+1/p-1/t9-,12-;/m1./s1
Other Options
| Image | Product Name | Manufacturer | Price Range | |
|---|---|---|---|---|
 | Cefazolin sodium salt | Supelco | ₹ 13,336.40 | |
| | Cefazolin sodium salt | Sigma Aldrich | ₹ 9,028.05 - ₹ 32,659.03 |
Related Products
Description
- General description: This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.
- Application: Cefazolin sodium BP Reference standard, intended for use in laboratory tests only as specifically prescribed in the British Pharmacopoeia. Also used in monographs such as:Cefazolin InjectionCefoxitin Injection
- Packaging: Unit quantity: 150 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity please visit British Pharmacopoeia
- Other Notes: Sales restrictions may apply.
SAFETY INFORMATION
Pictograms
Signal Word
Danger
Hazard Statements
Precautionary Statements
Hazard Classifications
Resp. Sens. 1 - Skin Sens. 1
WGK
WGK 2
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable
Compare Similar Items
Show Difference
grade: pharmaceutical primary standard
API family: cefazolin
form: powder
shelf life: limited shelf life, expiry date on the label
manufacturer/tradename: BP
application(s): pharmaceuticalpharmaceutical small molecule
format: neat
storage temp.: 2-8°C
SMILES string: [Na+].Cc1nnc(SCC2=C(N3[C@H](SC2)[C@H](NC(=O)Cn4cnnn4)C3=O)C([O-])=O)s1
InChI: 1S/C14H14N8O4S3.Na/c1-6-17-18-14(29-6)28-4-7-3-27-12-9(11(24)22(12)10(7)13(25)26)16-8(23)2-21-5-15-19-20-21;/h5,9,12H,2-4H2,1H3,(H,16,23)(H,25,26);/q;+1/p-1/t9-,12-;/m1./s1
grade:
pharmaceutical primary standard
API family:
cefazolin
form:
powder
shelf life:
limited shelf life, expiry date on the label
manufacturer/tradename:
BP
application(s):
pharmaceuticalpharmaceutical small molecule
format:
neat
storage temp.:
2-8°C
SMILES string:
[Na+].Cc1nnc(SCC2=C(N3[C@H](SC2)[C@H](NC(=O)Cn4cnnn4)C3=O)C([O-])=O)s1
InChI:
1S/C14H14N8O4S3.Na/c1-6-17-18-14(29-6)28-4-7-3-27-12-9(11(24)22(12)10(7)13(25)26)16-8(23)2-21-5-15-19-20-21;/h5,9,12H,2-4H2,1H3,(H,16,23)(H,25,26);/q;+1/p-1/t9-,12-;/m1./s1
grade: pharmaceutical primary standard
API family: cefoxitin
form: solid
shelf life: limited shelf life, expiry date on the label
manufacturer/tradename: BP
application(s): pharmaceuticalpharmaceutical small molecule
format: neat
storage temp.: 2-8°C
SMILES string: [Na+].CO[C@]2(NC(=O)Cc1cccs1)C3SCC(COC(N)=O)=C(N3C2=O)C([O-])=O
InChI: 1S/C16H17N3O7S2.Na/c1-25-16(18-10(20)5-9-3-2-4-27-9)13(23)19-11(12(21)22)8(6-26-15(17)24)7-28-14(16)19;/h2-4,14H,5-7H2,1H3,(H2,17,24)(H,18,20)(H,21,22);/q;+1/p-1/t14-,16+;/m1./s1
grade:
pharmaceutical primary standard
API family:
cefoxitin
form:
solid
shelf life:
limited shelf life, expiry date on the label
manufacturer/tradename:
BP
application(s):
pharmaceuticalpharmaceutical small molecule
format:
neat
storage temp.:
2-8°C
SMILES string:
[Na+].CO[C@]2(NC(=O)Cc1cccs1)C3SCC(COC(N)=O)=C(N3C2=O)C([O-])=O
InChI:
1S/C16H17N3O7S2.Na/c1-25-16(18-10(20)5-9-3-2-4-27-9)13(23)19-11(12(21)22)8(6-26-15(17)24)7-28-14(16)19;/h2-4,14H,5-7H2,1H3,(H2,17,24)(H,18,20)(H,21,22);/q;+1/p-1/t14-,16+;/m1./s1
grade: pharmaceutical primary standard
API family: nicotine
form: powder
shelf life: limited shelf life, expiry date on the label
manufacturer/tradename: BP
application(s): pharmaceuticalpharmaceutical small molecule
format: neat
storage temp.: 2-8°C
SMILES string: __
InChI: 1S/C17H15ClN2O3/c1-9(2)16(22)19-11-4-5-14(21)12(8-11)17-20-13-7-10(18)3-6-15(13)23-17/h3-9,20H,1-2H3,(H,19,22)/b17-12-
grade:
pharmaceutical primary standard
API family:
nicotine
form:
powder
shelf life:
limited shelf life, expiry date on the label
manufacturer/tradename:
BP
application(s):
pharmaceuticalpharmaceutical small molecule
format:
neat
storage temp.:
2-8°C
SMILES string:
__
InChI:
1S/C17H15ClN2O3/c1-9(2)16(22)19-11-4-5-14(21)12(8-11)17-20-13-7-10(18)3-6-15(13)23-17/h3-9,20H,1-2H3,(H,19,22)/b17-12-
grade: pharmaceutical primary standard
API family: doxepin
form: solid
shelf life: limited shelf life, expiry date on the label
manufacturer/tradename: BP
application(s): pharmaceuticalpharmaceutical small molecule
format: mixture
storage temp.: 2-8°C
SMILES string: Cl[H].CN(C)CC\C=C1/c2ccccc2COc3ccccc13
InChI: 1S/C19H21NO.ClH/c1-20(2)13-7-11-17-16-9-4-3-8-15(16)14-21-19-12-6-5-10-18(17)19;/h3-6,8-12H,7,13-14H2,1-2H3;1H/b17-11+;
grade:
pharmaceutical primary standard
API family:
doxepin
form:
solid
shelf life:
limited shelf life, expiry date on the label
manufacturer/tradename:
BP
application(s):
pharmaceuticalpharmaceutical small molecule
format:
mixture
storage temp.:
2-8°C
SMILES string:
Cl[H].CN(C)CC\C=C1/c2ccccc2COc3ccccc13
InChI:
1S/C19H21NO.ClH/c1-20(2)13-7-11-17-16-9-4-3-8-15(16)14-21-19-12-6-5-10-18(17)19;/h3-6,8-12H,7,13-14H2,1-2H3;1H/b17-11+;